Table 4. Univariate validation in the GSE25204+GSE73582 cohort.

	HR	95% CI	P-value
OS
miR-1183	0.93	0.81–1.07	0.311
miR-126-3p	0.85	0.63–1.15	0.288
miR-198	0.97	0.88–1.08	0.593
miR-23a-5p	0.93	0.70–1.24	0.629
miR-23a-3p	0.89	0.69–1.15	0.374
miR-27a-5p	1.16	0.95–1.41	0.148
miR-451a	0.93	0.78–1.10	0.399
miR-483-5p	1.09	0.97–1.23	0.158
miR-665	0.94	0.70–1.26	0.673
TTP
miR-125a-3p	1.06	0.93–1.21	0.376
miR-126-3p	1.18	0.95–1.47	0.129
miR-138-5p	1.18	0.99–1.41	0.066
miR-139-3p	1.20	1.01–1.43	0.035
miR-23a-5p	1.35	1.13–1.63	0.001
miR-23a-3p	1.11	0.92–1.34	0.292
miR-27a-5p	1.22	1.04–1.42	0.012
miR-27a-3p	1.04	0.87–1.25	0.633
miR-619-3p	1.04	0.91–1.20	0.540
miR-665	1.36	1.10–1.68	0.004
miR-802	1.01	0.82–1.25	0.923

OS = overall survival, HR = hazard ratio, CI = confidence interval, TTP = time to progression. Significant p-values are marked in bold.